1. Market Research
  2. > Pathology Industry
  3. > All premium reports
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

1-10 of about 400 reports for recombinant protein

Purchase Reports From Reputable Market Research Publishers

2014 Sales of Recombinant Therapeutic Antibodies & Proteins

2014 Sales of Recombinant Therapeutic Antibodies & Proteins

  • $ 132
  • Industry report
  • March 2015
  • by La Merie Publishing

2014 Sales of Recombinant Therapeutic Antibodies & Proteins This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant ...

Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins

Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins

  • $ 132
  • Industry report
  • March 2016
  • by La Merie Publishing

Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins This report prepared by La Merie Publishing provides a compilation of the sales data of originator recombinant therapeutic ...

Biosimilars Market: By Product (Recombinant Non-Glycosylated Protein, Recombinant Glycosated Proteins, Peptides) By Technology (Monoclonal Antibodies Technology, Nuclear Magnetic Resonance Technology, Recombinant DNA Technology, Chromatography, Mass Spect

Biosimilars Market: By Product (Recombinant Non-Glycosylated Protein, Recombinant Glycosated Proteins, Peptides) By Technology (Monoclonal Antibodies Technology, Nuclear Magnetic Resonance Technology, Recombinant DNA Technology, Chromatography, Mass Spect

  • $ 5250
  • Industry report
  • August 2015
  • by Industry ARC

BioSimilar is a bio pharmaceutical drug that have similar property to the drug previously licensed. As the number of diseased people increase, the demand for cheaper drugs also increase leading to increase ...

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilars Market: By Product (Recombinant Glycosated Proteins, Others) Technology (Chromatography, Mass Spectroscopy, Electrophoresis, Others) Application (Blood & Oncology Diseases, Chronic Diseases, Growth hormone deficiency, Others)-Forecast(2015-202

Biosimilars Market: By Product (Recombinant Glycosated Proteins, Others) Technology (Chromatography, Mass Spectroscopy, Electrophoresis, Others) Application (Blood & Oncology Diseases, Chronic Diseases, Growth hormone deficiency, Others)-Forecast(2015-202

  • $ 5250
  • Industry report
  • August 2015
  • by Industry ARC

BioSimilar is a bio pharmaceutical drug that have similar property to the drug previously licensed. As the number of diseased people increase, the demand for cheaper drugs also increase leading to increase ...

Global Biopharmaceuticals Industry

Global Biopharmaceuticals Industry

  • $ 4950
  • Industry report
  • May 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Biopharmaceuticals in US$ Million by the following Segments: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines. The report provides ...

Global Biopharmaceutical Market Report & Forecast (2016-2021)

Global Biopharmaceutical Market Report & Forecast (2016-2021)

  • $ 1500
  • Industry report
  • July 2016
  • by International Market Analysis Research and Consult

The global biopharmaceutical Industry has come a long way since its first drug- Humulin was approved in 1982. Today hundreds of biopharmaceuticals have already been approved and many more are in late stages ...

Global DNA Vaccine Market Outlook 2022

Global DNA Vaccine Market Outlook 2022

  • $ 1800
  • Industry report
  • August 2016
  • by RNCOS

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, ...

Analysis of the Global Biologics API Market

Analysis of the Global Biologics API Market

  • $ 3000
  • Industry report
  • July 2016
  • by Frost & Sullivan

Analysis of the Global Biologics API Market : Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies This study provides an insight into the global biologics active pharmaceutical ...

Non-alcoholic steatohepataitis (NASH) Pipeline Analysis

Non-alcoholic steatohepataitis (NASH) Pipeline Analysis

  • $ 3600
  • Industry report
  • February 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various ...

About 1500 reports for recombinant protein

Download Unlimited Documents from Trusted Public Sources

Protein Industry in Iran

  • January 2017
    6 pages
  • Protein  

    Recombinant Pro...  

    Immunochemistry...  

  • Iran  

View report >

Therapy Market

January 2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.